A detailed history of Goldman Sachs Group Inc transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 768,621 shares of IDXX stock, worth $317 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
768,621
Previous 815,358 5.73%
Holding current value
$317 Million
Previous $397 Million 2.28%
% of portfolio
0.06%
Previous 0.07%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$455.08 - $517.19 $21.3 Million - $24.2 Million
-46,737 Reduced 5.73%
768,621 $388 Million
Q2 2024

Aug 13, 2024

BUY
$468.04 - $548.53 $106 Million - $124 Million
225,771 Added 38.29%
815,358 $397 Million
Q1 2024

May 15, 2024

SELL
$515.08 - $576.87 $12.9 Million - $14.4 Million
-24,950 Reduced 4.06%
589,587 $318 Million
Q4 2023

Feb 13, 2024

BUY
$391.37 - $557.56 $28.3 Million - $40.3 Million
72,301 Added 13.33%
614,537 $341 Million
Q3 2023

May 14, 2024

SELL
$432.42 - $556.67 $31.3 Million - $40.2 Million
-72,301 Reduced 11.77%
542,236 $237 Million
Q3 2023

Nov 14, 2023

BUY
$432.42 - $556.67 $19.2 Million - $24.7 Million
44,395 Added 8.92%
542,236 $237 Million
Q2 2023

May 14, 2024

BUY
$450.7 - $503.61 $6.96 Million - $7.78 Million
15,450 Added 3.2%
497,841 $250 Million
Q2 2023

Aug 14, 2023

BUY
$450.7 - $503.61 $6.96 Million - $7.78 Million
15,450 Added 3.2%
497,841 $250 Million
Q1 2023

May 14, 2024

BUY
$406.01 - $514.59 $45.9 Million - $58.2 Million
113,027 Added 30.6%
482,391 $241 Million
Q1 2023

May 11, 2023

BUY
$406.01 - $514.59 $45.9 Million - $58.2 Million
113,027 Added 30.6%
482,391 $241 Million
Q4 2022

May 14, 2024

SELL
$324.64 - $441.27 $11 Million - $15 Million
-34,019 Reduced 8.43%
369,364 $151 Million
Q4 2022

Feb 13, 2023

SELL
$324.64 - $441.27 $11 Million - $15 Million
-34,019 Reduced 8.43%
369,364 $151 Million
Q3 2022

May 14, 2024

BUY
$325.8 - $407.78 $3.39 Million - $4.24 Million
10,401 Added 2.65%
403,383 $131 Million
Q3 2022

Nov 10, 2022

BUY
$325.8 - $407.78 $3.39 Million - $4.24 Million
10,401 Added 2.65%
403,383 $131 Million
Q2 2022

May 14, 2024

SELL
$327.37 - $553.44 $72.5 Million - $123 Million
-221,555 Reduced 36.05%
392,982 $138 Million
Q2 2022

Aug 15, 2022

BUY
$327.37 - $553.44 $2.3 Million - $3.88 Million
7,019 Added 1.82%
392,982 $138 Million
Q1 2022

May 16, 2022

BUY
$466.52 - $631.01 $33.3 Million - $45 Million
71,372 Added 22.69%
385,963 $211 Million
Q4 2021

Feb 14, 2022

SELL
$586.54 - $666.48 $15.3 Million - $17.3 Million
-26,020 Reduced 7.64%
314,591 $207 Million
Q3 2021

Nov 10, 2021

BUY
$621.9 - $705.76 $212 Million - $240 Million
340,611 New
340,611 $212 Million

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $34.3B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.